[xoo_el_inline_form active="login"]

Banner1
Banner1 Mb
Banner2
Banner2 Mb
Banner3
Banner3 Mb
Armor Suits

CytoArm create armor suits
Aim to cure all diseases

CytoArm’s technology is based on cell immunotherapy and antibody engineering.We focus on developing drugs with high selectivity to target tumor cells without harming normal cells.

Complete Armed-T cell portfolio
“We Cover more than 50 diseases”

We focus on developing drugs with high selectivity to target tumor cells without harming normal cells.

・Armed-T Cell Therapy

Armed patients’ T cells with bispecific antibodies to activate T cells and teach them to recognize and attack tumor cells.

00007icon
00001icon
00002icon
00003icon
00004icon
00005icon
00006icon
Line

Members

Cytoarm 莊國祥

Kuo-Hsiang Chuang

Ph.D.
Chief Executive Officer
Cytoarm 陳桂恆

Keith Chan

Ph.D.
Regulations & Operation Strategy
Cytoarm 湯竣鈞

Winston Town

Ph.D.
Finance & Business Management
Cytoarm Bob Hsieh

Bob Hsieh

Ph.D.
International Affairs
Cytoarm Ting Yu Chen

Ting-Yu Chen

Ph.D.
Vice President, R&D
Mei Lin Liu

Mei-Lin LIU

MBA
Chief Finance Officer
Chang Hung Wang

Chang-Hung WANG

Ph.D.
QC/QA Specialist
Chien Hui Yang

Chien-Hui YANG

CMC Specialist
Che Yi Chen

Che-Yi CHEN

Ph.D.
Clinical Research Associate
Tung Yun Wu03

Tung-Yun WU

Ph.D.
R&D Specialist